Delcath Systems, Inc.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery s…

Medical - Specialties

US, New York [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Delcath Systems, Inc.

Institutional

Insider

Retail

38.13%

2.71%

59.16%

Intraday

Shares Outstanding

31,973,800

Volume

128,482

Volume on Avg.

419,270

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $12.95 per share	Last Form/Filing	Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Czerepak Elizabeth Internal : EVP & Chief Financial Officer	0	$0	05/28/24	0 x $0 = $0
Salamon Steven A J Internal : Director	3,013,468	$39,024,410.60	12/27/24	C 250,000 x $10.00 = $2,500,000.00
Aharon Gil Internal : Director	0	$0	11/01/24	0 x $0 = $0
Michel Gerard J Internal : CHIEF EXECUTIVE OFFICER	0	$0	02/14/24	0 x $0 = $0
Sylvester John Richard Internal : Director	10,550	$136,622.50	08/23/23	P 10,550 x $4.80 = $50,640.00
Martell Bridget A Internal : Director	0	$0	05/28/24	0 x $0 = $0
Stoll Roger G Phd Internal : Director	0	$0	05/28/24	0 x $0 = $0
Rook Martha S. Internal : CHIEF OPERATING OFFICER	0	$0	03/20/24	0 x $0 = $0
Vukovic Vojo Internal : CHIEF MEDICAL OFFICER	60,000	$777,000.00	11/20/23	P 60,000 x $2.48 = $148,800.00
Pennell Sandra Internal : SVP OF FINANCE, PFO AND PAO	0	$0	02/14/24	0 x $0 = $0
Muir Kevin Internal : GM INTERVENTIONAL ONCOLOGY	0	$0	01/26/24	0 x $0 = $0
Hoffman David L. Internal : GEN'L COUNSEL, CCO & SECY	74,330	$962,573.50	03/19/24	A 20,161 x $3.72 = $74,998.92
Dias Anthony Internal : VP FINANCE	0	$0	02/20/24	0 x $0 = $0
Purpura John Internal : CHIEF OPERATING OFFICER	0	$0	01/26/24	0 x $0 = $0
John Johnny Internal : SVP CLINICAL DEV & MED AFFAIRS	0	$0	01/26/24	0 x $0 = $0